Literature DB >> 19771404

[Inside-Out. Probiotics and atopic dermatitis].

T Werfel1.   

Abstract

Orally administered probiotics have been employed for the prevention and therapy of atopic dermatitis in recent years, because both theoretical considerations and animal models suggested positive effects were likely. Current clinical studies make it clear that oral probiotics are not indicated for the therapy of mild, moderate or severe atopic dermatitis. A prevention study from Finland described a marked positive effect of lactobacilli on the rate of atopic dermatitis when the bacteria were given orally to the pregnant mother and the newborn. However, these positive results could not be reproduced by other investigators. Until these varying results are explained, no recommendation can be made for use of oral probiotics to prevent atopic dermatitis, as is stated in the current German S3 guideline on the prevention of allergies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19771404     DOI: 10.1007/s00105-009-1756-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial.

Authors:  Kaarina Kukkonen; Erkki Savilahti; Tari Haahtela; Kaisu Juntunen-Backman; Riitta Korpela; Tuija Poussa; Tuula Tuure; Mikael Kuitunen
Journal:  J Allergy Clin Immunol       Date:  2006-10-23       Impact factor: 10.793

2.  [Atopic dermatitis: S2 guidelines].

Authors:  Thomas Werfel; Werner Aberer; Matthias Augustin; Tilo Biedermann; Regina Fölster-Holst; Frank Friedrichs; Uwe Gieler; Annice Heratizadeh; Alexander Kapp; Bernhard Przybilla; Ernst Rietschel; Martin Schlaeger; Peter Schmid-Grendelmeier; Helmut Sitters; Doris Staab; Rüdiger Szczepanski; Dieter Vieluf; Ingrid Voigtmann; Margitta Worm
Journal:  J Dtsch Dermatol Ges       Date:  2009-01       Impact factor: 5.584

3.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.

Authors:  M Kalliomäki; S Salminen; H Arvilommi; P Kero; P Koskinen; E Isolauri
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

4.  Effect of probiotic Lactobacillus strains in children with atopic dermatitis.

Authors:  Vibeke Rosenfeldt; Eva Benfeldt; Susanne Dam Nielsen; Kim Fleischer Michaelsen; Dorthe Lisbeth Jeppesen; Niels Henrik Valerius; Anders Paerregaard
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

5.  Probiotics in the management of atopic eczema.

Authors:  E Isolauri; T Arvola; Y Sütas; E Moilanen; S Salminen
Journal:  Clin Exp Allergy       Date:  2000-11       Impact factor: 5.018

6.  Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.

Authors:  R Fölster-Holst; F Müller; N Schnopp; D Abeck; I Kreiselmaier; T Lenz; U von Rüden; J Schrezenmeir; E Christophers; M Weichenthal
Journal:  Br J Dermatol       Date:  2006-12       Impact factor: 9.302

7.  Is the effect of probiotics on atopic dermatitis confined to food sensitized children?

Authors:  D Sistek; R Kelly; K Wickens; T Stanley; P Fitzharris; J Crane
Journal:  Clin Exp Allergy       Date:  2006-05       Impact factor: 5.018

8.  Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

Authors:  Marko Kalliomäki; Seppo Salminen; Tuija Poussa; Heikki Arvilommi; Erika Isolauri
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

9.  Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy.

Authors:  C Grüber; M Wendt; C Sulser; S Lau; M Kulig; U Wahn; T Werfel; B Niggemann
Journal:  Allergy       Date:  2007-11       Impact factor: 13.146

10.  Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.

Authors:  Matthias Volkmar Kopp; Isabell Hennemuth; Andrea Heinzmann; Radvan Urbanek
Journal:  Pediatrics       Date:  2008-03-10       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.